
A study was conducted to evaluate the acceptance, effectiveness, and complications of postpartum intrauterine contraceptive device (PPIUCD) in a tertiary center. The study included pregnant women who were over 34 weeks gestational age and attended antenatal care between January and September 2020. The overall acceptance rate of PPIUCD was 36.23%, with fear of pain, bleeding, and complications being the main reasons for refusal. The majority of insertions were postplacental (80%), with postcaesarean and postabortal insertions accounting for 18% and 2%, respectively. Complications occurred in 14% of women, including abdominal pain, heavy menstrual bleeding, and infection. At one year of follow-up, none of the women had conceived, demonstrating the 100% efficacy of PPIUCD as a contraceptive. Despite low awareness, PPIUCD was found to be an effective and safe long-acting reversible contraception method.
Like
Save
Share